against people with obesity. This raises concerns about the future of provider-patient relationships and care outcomes for patients dealing with weight-related issues, especially women ...

As part of the Johns Hopkins All Children’s Heart Institute, Hernandez provides patients with a multi-tiered approach including innovative clinical care, research and educational efforts targeting ...

Some said that seeing these menu labels actually reinforced the beliefs behind their eating disorders, researchers added. “It’s definitely set my recovery back by a long way and I only feel safe ...

A hospital phoned for an ambulance so an elderly patient could be driven 400m to A&E to have a catheter replaced, says his daughter. Staff called 999, before paramedics arrived to transfer Brian ...

Fortress Biotech (FBIO) and its majority-owned subsidiary, Helocyte, announced that the first patient was dosed in a multicenter, placebo-controlled and randomized Phase 2 clinical trial to ...

The patent application covers methods of treating obese patients by administering Namodenoson in an oral formulation. Can-Fite has already multiple approved patents and corresponding applications ...

Enobosarm was tested in 168 overweight or obese patients aged 60 years and above, who are at a greater risk of falls and fractures. The drug targets the androgen receptors present in skeletal ...

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study offers one available option: bariatric surgery. Weight loss operations ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes ... a slow-release compound that patients could one day have access to at an annual checkup and then not have ...

A doctor accused of murdering four elderly patients is feared to have killed at least 60 people by injecting them with a lethal cocktail of drugs. The 40-year-old doctor, named only as Johannes M., ...

Yet, this trend does not mean that all candidates for GLP-1s with overweight/obesity are eager to embrace their use. Recommending GLP-1s for a patient may begin with addressing their deeply valid ...